HbA1c for screening and diagnosis of diabetes mellitus

Endocrine

Volumn 43, Issue 2, 2013, Pages 266-273

  Higgins, Trefor ^a  

^a DynaLIFE Dx   (Canada)

Author keywords

Diabetes mellitus; Diagnosis; Glycated hemoglobin; Screening

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; HEALTH CARE COST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MEDICAL HISTORY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING TEST; ADOLESCENT; ADULT; AGED; BLOOD; CASE REPORT; ECONOMICS; FEMALE; GLUCOSE TOLERANCE TEST; MASS SCREENING; METABOLISM; METHODOLOGY; STANDARD; PROCEDURES; STANDARDS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING;

EID: 84879552207     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9768-y     Document Type: Review

References (82)

1. S.W. Wild, G. Roglic, A.G. Green, R. Sicree, H. King, Global prevalence of diabetes. Diabetes Care 27, 1047-1053 (2004)
2. International Diabetes Foundation, Diabetes Atlas, 3rd ed. (IDF, Brussels, 2008)
3. P. Onkamo, S. Vaänänen, M. Karvonen, J. Tuomilento, Worldwide increase in incidence of type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 42, 1395-1403 (1999)
4. M.C. Thomas, S.L. Hardoon, A.O. Papacosta, R.W. Morris, S.G. Wannamethee, A. Sloggett, P.H. Whincup, Evidence of an accelerating increase in prevalence of diagnosed type 2 diabetes in British men, 1978-2005. Diabet. Med. 26, 756-772 (2009)
5. A. Ohinmaa, J. Jacobs, S. Simpson, J.A. Johnson, The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can. J. Diabetes 28, 116-123 (2004)
6. C.C. Cowie, K.F. Rust, E.S. Ford, M.S. Eberhardt, D.D. Byrd-Holt, C. Li et al., Full accounting of diabetes and pre-diabetes in U.S. populations in 1988-1994 and 2005-2006. Diabetes Care 32, 287-294 (2009)
7. W. Yang, K.H. Yoon, F.B. Hu, Diabetes in Asia. N. Engl. J. Med. 36, 1090-1101 (2010)
8. J.C. Chan, V. Malik, W. Jia, T. Kadowaki, C.S. Yaijnik, K.H. Yoon, F.B. Hu, Diabetes in Asia: epidemiology, risk factors and pathophysiology. JAMA 301, 2129-2140 (2009)
9. W.M. Wannazaimoon, M. Suraiami, Prevalence of diabetes, impaired fasting glucose and metabolic syndrome among female Orang Asli community in Penninsular Malaysia. Int. J. Diabetes Dev. Ctries. 30, 118-122 (2010)
10. G. Roglic, N. Unwin, P.H. Bennett, C. Mathers, J. Tuomilhrto, S. Nag et al., The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28, 2130-2135 (2005)
11. ADA, Economic costs of diabetes in the US in 2007. Diabetes Care 32, 1090-1091 (2008)
12. K. Santos-Rey, P. Fernandez-Riejos, J. Mateo, V. Sanchez-Margalet, R. Gaberna, Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion on impaired glucose tolerance in high-risk individuals. Clin. Chem. Lab. Med. 48, 1719-1722 (2010)
13. G.T. Ko, J.C. Chan, J. Woo, E. Lau, V.T. Yeung, C.C. Chow et al., The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Clin. Biochem. 35, 62-67 (1998)
14. A.W. Lyon, E.T. Larsen, A.L. Edwards, The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services. CMAJ 171(9), 1067-1069 (2004)
15. C.D. Saudek, W.H. Herman, D.B. Sacks, R.M. Bergenstal, D. Edelman, M.B. Davison, A new look at screening and diagnosing diabetes mellitus. J. Clin. Endocrinol. Metab. 93, 447-453 (2008)
16. 1c assay in the diagnosis of diabetes. Diabetes Care 32, 1327-1334 (2009)
17. 1c) in the diagnosis of diabetes mellitus. WHO website. http://www.who.int/entity/diabetes/ publications/report-hba1c-2011.pdf. Accessed 2 Mar 2012
18. 1c for the diagnosis of diabetes. Endocr. Pract. 16, 1555-1556 (2010)
19. 1c) in the diagnosis of type 2 diabetes mellitus in adults. Can. J. Diabetes 7, 247-248 (2011)
20. 1c to diagnosis diabetes; why the controversy over adding a new tool? Clin. Chem. 57, 255-257 (2009)
21. 1c in diabetes diagnosis: time for caution. Endocr. Pract. 16, 5-6 (2010)
22. 1c. J. Int. Med. 271, 227-236 (2012)
23. 1c for diagnosing diabetes mellitus. Am. J. Med. 124, 395-401 (2010)
24. 1c a step forward for diagnosing diabetes? BMJ 339, 1288-1290 (2009)
25. 1c a good screening test for diabetes? Clin. Biochem. 44, 1469-1472 (2011)
26. 1C-based diagnostic criteria. Diabetes Care 33, 2184-2189 (2010)
27. 1c and glucose levels in the general Dutch population. The new Hoorn Study. Diabetes Care 33, 61-66 (2010)
28. 1c assay in the diagnosis of diabetes. Diabetes Care 32, c59 (2009)
29. 1c assay in the diagnosis of diabetes. Diabetes Care 12, c160 (2009)
30. 1C-based diagnostic criteria. Diabetes Care 33, c174 (2010)
31. 1c will impact clinical laboratories. Clin. Chem. 55, 1612-1614 (2009)
32. 1c assay in the diagnosis of diabetes. Diabetes Care 12, c160 (2010)
33. E.S. Kilpatrick, P.W. Maylor, B.G. Keevil, Biological variation of glycated hemoglobin. Implications for diabetes and monitoring. Diabetes Care 21, 261-264 (1998)
34. 1c reference ranges. J. Diabetes Sci. Technol. 3, 644-648 (2009)
35. L.N. Pani, L. Korenda, J.B. Meigs, C. Driver, S. Charmany, C.S. Fox et al., Effect of aging on A1C levels without diabetes: evidence from the Framingham Offspring study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 31, 1991-1996 (2008)
36. 1c). J. Gerentol. 37, 648-650 (1982)
37. 1c in a working male Japanese population. Diabetes Care 18, 1337-1340 (1995)
38. 1c: a study in a healthy Chinese population. Diabetes Care 20, 988-991 (1997)
39. 1c values in non-diabetic subjects. Clin. Chem. Lab. Med. 42, 423-428 (2004)
40. 1c in children and adolescents with diabetes in relation to certain clinical parameters. The Swedish childhood registry, SWEDIABKIDS. Diabetes Care 31, 927-929 (2008)
41. D. Dilli, I. Bostanci, Y. Dallar, S. Gücük, Glycohemoglobin screening in adolescents attending to the department of paediatrics at a tertiary hospital in Turkey. Diabetes Res. Clin. Res. 79, 305-309 (2008)
42. 1c on mortality in adults with diabetes: findings from a national population based follow up. Circulation 118S, 1134 (abstract) (2008)
43. 1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 30, 2453-2457 (2007)
44. J.K. Kirk, L.V. Passmore, R.A. Bell, K.M. Narayan, R.B. D'Agostino, T.A. Arcury et al., Disparities between Hispanic and non-Hispanic white adults with diabetes: a meta analysis. Diabetes Care 31, 240-246 (2008)
45. N. De Rekeneire, R.N. Rooks, E.M. Simonsick, R.I. Shorr, L.H. Kuller, A.V. Schwartz et al., Health, aging and body composition in glycemic control in a well-functioning older diabetic population; findings from the health, aging and body composition study. Diabetes Care 26, 1986-1992 (2003)
46. A.S. Adams, F. Khang, C. Mah, R.W. Grant, K. Kleinman, J.B. Meiges, D. Ross-Degnan, Race differences in long-term diabetes management in a HMO. Diabetes Care 28, 2844-2849 (2005)
47. 1c on mortality in adults with diabetes: findings from a national population based follow up. Circulation 118S, 1134 (abstract) (2009)
48. H. Ishi, H. Suzuki, T. Baba, K. Nakamura, T. Watanabe, Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care 24, 1503 (2001)
49. 1c levels without weight change in male patients with type 2 diabetes treated with insulin. Diabetes Care 27, 1238-1239 (2004)
50. 1c in adult patients. Diabetes Care 20, 234 (1997)
51. S. Norfeldt, J. Ludvigsson, Seasonal variation in intensive treatment of children with type 1 diabetes. J. Pediatr. Endrocrinol. Metab. 13, 429-435 (2000)
52. 1c in patients with type 2 diabetes mellitus. Diabet. Med. 17, 554-555 (2000)
53. 1c values. Am. J. Epidemiol. 161, 565-574 (2005)
54. 1c, IgA, prolactin and free testosterone in health women. Clin. Chem. 46, 551-559 (2000)
55. 1c: is it the same in both hemispheres? J. Diabetes Sci. Technol. 3, 668-671 (2009)
56. H.S. Chen, T.S. Jap, R.L. Chen, H.D. Lin, A prospective study of glycemic control during holiday time in type 2 diabetes patients. Diabetes Care 27, 326-330 (2004)
57. R.C. Hawkins, Circannual variation in glycohemoglobin in Singapore. Clin. Chim. Acta 411, 18-21 (2010)
58. P.K. Khera, C.H. Joiner, A. Carruthers, C.J. Lindsell, E.P. Smith, R.S. Franco et al., Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 57, 2445-2452 (2008)
59. J.M. Hempe, R. Gomez, R.J. McCarter, S.A. Chalew, High and low hemoglobin phenotype in type 1 diabetes: a challenge for interpretation of glycemic control. J. Diabetes Complicat. 16, 313-320 (2002)
60. 1c in nondiabetic patients. Acta Haematol. 112, 126-128 (2004)
61. 1c underestimates glycemia in HIV infections. Diabetes Care 32, 1591-1593 (2009)
62. 1c level in periodontitis among insulin-dependent diabetic patients. J. Clin. Periodontal. 10, 871-875 (2003)
63. 1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab. 30, 261-268 (2004)
64. 1c values in diabetic patients receiving interferon alpha and ribavirin for chronic hepatitis C. J. Viral Hepat. 13, 613-617 (2006)
65. 1c levels in a patient receiving ribavirin and peginterferon alfa-2b for hepatitis C. Pharmacotherapy 29, 121-123 (2009)
66. 1c - good diabetic control? Clin. Chem. 58, 648-649 (2012)
67. 1c) by 23 methods. Clin. Chem. 54, 1277-1282 (2008)
68. T. Lee, C.W. Weykamp, Y.-W. Lee, J.-W. Kim, C.-S. Ki, Effects of 7 hemoglobin variants on the measurement of glycohemoglobin by 14 analytical methods. Clin. Chem. 53, 2002-2005 (2007)
69. L. Bry, P.C. Chan, D.B. Sacks, Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin. Chem. 47, 153-163 (2001)
70. E.L. Frank, L. Moulton, R.R. Little, H.-M. Wiedmeyer, C. Rohlfing, W.L. Roberts, Effects of hemoglobin C and S traits on 7 glycohemoglobin methods. Clin. Chem. 46, 864-867 (2000)
71. W.L. Roberts, B.K. De, C.M. Hanbury, J.D. Hoyer, W.G. John, T.L. Lambert et al., Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin. Chem. 48, 383-385 (2002)
72. W.L. Roberts, S. Safar-Pour, B.K. De, C.L. Rohlfing, C.W. Weykamp, R.R. Little, Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin. Chem. 51, 776-778 (2005)
73. W.L. Roberts, Hemoglobin constant spring can interfere with glycated hemoglobin measurements by boronate affinity chromatography. Clin. Chem. 53, 142-143 (2007)
74. 1c analysis and reporting: an interesting case illustrating the many pitfalls. Clin. Biochem. 41, 1104-1106 (2008)
75. 1c methods compared with the IFCC reference method. Am. J. Clin. Pathol. 129, 811-814 (2008)
76. R.M. Cohen, A1C: does one size fit all? Diabetes Care 30, 2756-2758 (2007)
77. D.B. Sacks, M. Arnold, D.E. Bakaria, D.E. Bruns, A.R. Horvath, M.S. Kirkman et al., Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin. Chem. 57, e1-e47 (2011)
78. S.E. Wilson, L.L. Lipscombe, L.C. Rosetta, D.G. Manuel, Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: population-based study. BMC Health. Serv. Res. 9, 41 (2009)
79. 1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet. Med. 26, 115-121 (2009)
80. 1c in screening for undiagnosed diabetes in the US population. J. Gen. Intern. Med. 23, 346-353 (2009)
81. S.J. Davie, B.J. Gould, J.S. Yudik, Effects of vitamin C on glycosylation of proteins. Diabetes 41, 167-173 (1991)
82. J.D. Hoyer, S.H. Kroft, in Color Atlas of Hemoglobin Disorders, (College of American Pathologists, Northfield, (2003)), case 45